Rockwell Medical (STU:RWM) Cyclically Adjusted FCF per Share: €-30.42 (As of Mar. 2026)


STU:RWM Rockwell Medical Inc STU:RWM
26 GF Score
Price €4.80
GF Value €0.82
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Rockwell Medical Cyclically Adjusted FCF per Share?

Rockwell Medical STU:RWM 26 Cyclically Adjusted FCF per Share is €-30.42 as of Mar. 2026. GuruFocus rates STU:RWM with a GF Score™ of 26/100 and a GF Value™ of €0.82 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Rockwell Medical's adjusted free cash flow per share for the three months ended in Mar. 2026 was €-0.130. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-30.42 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 16.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Rockwell Medical was 20.50% per year. The lowest was -37.70% per year. And the median was -1.60% per year.

As of today (2026-07-05), Rockwell Medical's current stock price is €4.80. Rockwell Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €-30.42. Rockwell Medical's Cyclically Adjusted Price-to-FCF of today is .


Rockwell Medical  (STU:RWM) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Rockwell Medical Cyclically Adjusted FCF per Share Related Terms


Rockwell Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Rockwell Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical Cyclically Adjusted FCF per Share Chart

Rockwell Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -576.98 -55.26 -339.19 -380.67 -287.00

Rockwell Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -347.80 -301.69 -316.07 -287.00 -30.42

STU:RWM vs CPHI, TXMD, MRMD: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Cyclically Adjusted Price-to-FCF falls into.


STU:RWM
26GF Score
Rockwell Medical Inc STU:RWM
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rockwell Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rockwell Medical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.13/330.2130*330.2130
=-0.130

Current CPI (Mar. 2026) = 330.2130.

Rockwell Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -10.148 241.018 -13.904
201609 -13.132 241.428 -17.961
201612 1.043 241.432 1.427
201703 -10.625 243.801 -14.391
201706 -13.963 244.955 -18.823
201709 -8.084 246.819 -10.815
201712 -10.494 246.524 -14.056
201803 -8.290 249.554 -10.969
201806 -9.983 251.989 -13.082
201809 -9.247 252.439 -12.096
201812 -10.421 251.233 -13.697
201903 -9.882 254.202 -12.837
201906 -18.047 256.143 -23.266
201909 -10.286 256.759 -13.229
201912 -8.353 256.974 -10.734
202003 -9.936 258.115 -12.711
202006 -13.645 257.797 -17.478
202009 -7.286 260.280 -9.244
202012 -8.340 260.474 -10.573
202103 -12.371 264.877 -15.422
202106 -5.048 271.696 -6.135
202109 -7.177 274.310 -8.640
202112 -9.472 278.802 -11.219
202203 -10.461 287.504 -12.015
202206 -4.860 296.311 -5.416
202209 -0.667 296.808 -0.742
202212 -0.100 296.797 -0.111
202303 -2.045 301.836 -2.237
202306 -0.908 305.109 -0.983
202309 -1.283 307.789 -1.376
202312 -0.027 306.746 -0.029
202403 -0.790 312.332 -0.835
202406 0.335 314.175 0.352
202409 1.135 315.301 1.189
202412 0.137 315.605 0.143
202503 -0.962 319.799 -0.993
202506 0.425 322.561 0.435
202509 -0.363 324.800 -0.369
202512 0.478 324.054 0.487
202603 -0.130 330.213 -0.130

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €-30.42 mean?
Rockwell Medical (STU:RWM) has a Cyclically Adjusted FCF per Share of €-30.42 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Rockwell Medical and its competitors.
Is Rockwell Medical's Cyclically Adjusted FCF per Share too high?
Rockwell Medical's current Cyclically Adjusted FCF per Share is €-30.42. Overall, Rockwell Medical has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's Cyclically Adjusted FCF per Share compare to CPHI and TXMD?
Rockwell Medical's Cyclically Adjusted FCF per Share of €-30.42 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Rockwell Medical and its competitors. Rockwell Medical's current Cyclically Adjusted FCF per Share is €-30.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (STU:RWM) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.82, compared to a current price of €4.80 — trading 485.4% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €-30.42. Rockwell Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Rockwell Medical (STU:RWM), the current Cyclically Adjusted FCF per Share is €-30.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rockwell Medical (STU:RWM) Overvalued in 2026?

Based on GuruFocus' analysis, Rockwell Medical stock appears to be overvalued. The current stock price of €4.80 is trading 485.4% above its estimated GF Value™ of €0.82. GuruFocus considers Rockwell Medical to be Significantly Overvalued.

Key valuation signals for STU:RWM:

  • Cyclically Adjusted FCF per Share: €-30.42
  • GF Value™: €0.82 vs. price of €4.80 (485.4% above fair value)
  • GF Score™: 26/100 with 3 warning signs

No single metric tells the full story. See the STU:RWM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rockwell Medical Business Description

Other Exchanges RMTI:USARWMA:Germany
Address 30142 South Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
26GF Score

Get the complete analysis for STU:RWM

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.80
Price
€0.82
GF Value